Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Minoxidil boosts hair growth by activating PGHS-1.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

New tests detect finasteride and dutasteride in urine quickly and easily.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Mobile phone radiation may cause DNA damage in human ear hair follicle cells.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

The authors suggest systematically sourcing new product ideas from various internal and external places to improve innovation.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

A plant mixture extract helped grow hair by boosting cell growth and growth factors while blocking a hair loss-related enzyme.

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.